相互作用
Brexucabtagene autoleucel + Mitoxantrone
重症度: 重大
Brexucabtagene autoleucel and Mitoxantrone: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Mitoxantrone is a myelosuppressive, immunosuppressive cytotoxic agent. Recent or concurrent use around CAR T therapy may impair T-cell collection and expansion and increase infection and cytopenia risk.
この相互作用をわかりやすく説明すると
Brexucabtagene autoleucel and Mitoxantrone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Mitoxantrone belongs to Central Nervous System.
なぜ起こるのか
Additive cytotoxic and immunosuppressive effects on lymphocytes and marrow.
対処法
Observe an adequate washout of mitoxantrone before leukapheresis, and avoid it after infusion unless clinically required. Monitor blood counts and infection closely.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Brexucabtagene autoleucelとMitoxantroneの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Mitoxantroneのその他の相互作用
Brexucabtagene autoleucelのその他の相互作用
よくある質問
Can I take Brexucabtagene autoleucel with Mitoxantrone?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Mitoxantrone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mitoxantrone is a myelosuppressive, immunosuppressive cytotoxic agent. Recent or concurrent use around CAR T therapy may impair T-cell collection and expansion and increase infection and cytopenia risk.
How serious is the interaction between Brexucabtagene autoleucel and Mitoxantrone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Observe an adequate washout of mitoxantrone before leukapheresis, and avoid it after infusion unless clinically required. Monitor blood counts and infection closely.
What other medicines interact with Mitoxantrone?
MediHelp also lists interactions of Mitoxantrone with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Mitoxantrone page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
